Addressing patients with chronic kidney disease requires a commitment to data, education, and community, specifically in those affected by social determinants of health (SDOH).

This is the third indication for Fabhalta after Novartis won FDA approval of the small molecule in paroxysmal nocturnal hemoglobinuria and primary immunoglobulin A nephropathy.

Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts spotted several shortfalls in the drug's label, leaving more to be desired—and ...

Sun exposure can help most people boost their vitamin D levels. Your body makes vitamin D when cells in your skin come into ...

FY 2024 Earnings Highlights: Revenue: KD 286.1 million, up by 5.5%. Operating Profit KD 22.5 million, up by 19.0%. EBITDA: KD 31.5 million, up by 12.9%.

Uganda has made significant strides in kidney care, including the establishment of dialysis centres and successful kidney ...

scPharmaceuticals reported a net loss of $18.8 million for the fourth quarter of 2024, compared to $13.8 million for the fourth quarter of 2023. For the full-year 2024, scPharmaceuticals reported a ...

The article discusses the significance of kidney health, highlighting that kidney disease often goes unnoticed until advanced ...

Bayer has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its kidney-disease drug Kerendia in certain people with heart failure.

With nearly 2 lakh new cases of kidney failure diagnosed annually in India, Chronic Kidney Disease is a growing health ...

Discover these kidney-friendly superfoods that can help manage symptoms, provide essential nutrients, and add delicious ...

A TikTok creator ended up in the hospital with kidney stones after consuming excessive protein on the trending carnivore diet.